
Organometallic Ligands
Subcategories of "Organometallic Ligands"
- Buchwald Ligands(22 products)
- DPEN(4 products)
- DPHEN(4 products)
- JOSIPHOS(4 products)
- Phosphine(497 products)
- Porphirines(75 products)
Found 2889 products of "Organometallic Ligands"
Fluvastatin sodium
CAS:Fluvastatin is a statin that lowers blood cholesterol and triglycerides by inhibiting HMG-CoA reductase, an enzyme that plays a critical role in the synthesis of cholesterol. Fluvastatin has also been shown to reduce the incidence of myocardial infarction, and to reduce atherosclerotic lesions in animal models, reducing the incidence of cardiovascular disease. Fluvastatin also has been shown to inhibit the activation of toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS), which may be related to its anti-inflammatory effects. Furthermore, through lowering blood cholesterol, Fluvastatin also inhibits tubulointerstitial injury and prevents renal damage caused by high concentrations of the lipid.
Formula:C24H25FNNaO4Purity:Min. 98%Color and Shape:Off-White PowderMolecular weight:433.45 g/molApixaban - Bio-X ™
CAS:Apixaban is an anticoagulant agent used for the prophylaxis of stroke and deep vein thrombosis leading to pulmonary embolism. This drug is an inhibitor of factor Xa and prothrominase. As a result, this prevents the formation of a thrombus.Formula:C25H25N5O4Purity:Min. 95%Color and Shape:PowderMolecular weight:459.5 g/molRosuvastatin calcium - Bio-X ™
CAS:Rosuvastatin is a drug that belongs to the group of statins. It is used for the treatment of high cholesterol and as an adjunct therapy for patients with coronary heart disease. Rosuvastatin reduces serum cholesterol by inhibiting HMG-CoA reductase, which is the rate-limiting enzyme in the production of cholesterol. Furthermore, this drug has been shown to have anti-inflammatory properties, which may be due to its ability to inhibit prostaglandin synthesis.Formula:C22H27FN3O6SCaPurity:(%) Min. 95%Color and Shape:PowderMolecular weight:500.57 g/molKifunensine - Bio-X ™
CAS:Kifunensine is a small molecule inhibitor that was designed and synthesized to inhibit plant and animal α-mannosidase I. It is a potent and specific inhibitor with IC50 in nanomolar range. It inhibits the enzyme isoforms in Golgi apparatus (GMI) and endoplasmatic reticulum (ERMI). The compound prevents mannose trimming on glycoproteins and shifts the glycoform content from complex to oligomannose type. Used for the production of recombinant therapeutic glycoproteins with mannose rich N-linked glycans.Formula:C8H12N2O6Purity:Min. 95%Color and Shape:White PowderMolecular weight:232.19 g/molProtein tyrosine phosphatase (PTP) substrate
The sequence of this peptide has been derived from a highly conserved region of the T-cell phosphatase TC.PTP45 and is an excellent general substrate for protein tyrosine phosphatases.The protein tyrosine phosphatase (PTP) superfamily has 103 enzymes that catalyse substrate dephosphorylation at tyrosine residues through a covalent enzyme intermediate involving a thiophosphate linkage from the active site cysteine residue. All PTPs share a common signature motif (I/V)HCXAGXGR(S/T), named the P-loop, responsible for the enzyme activity. The PTP superfamily can be divided into four classes based on their cellular localization/catalytic domains: the receptor-like PTPs (rPTPs), the non-receptor PTPs (nrPTPs), the low molecular weight PTP (LMWPTP), and the VH-1 and CDC-25 groups.PTPs are involved in regulating a plethora of cellular activities, including proliferation and differentiation, survival, migration, metabolism, and the immune response. Abnormal protein tyrosine phosphorylation has been associated with the etiology of various human diseases, including cancer, diabetes, and autoimmune dysfunctions, therefore making PTPs novel therapeutic targets.Purity:Min. 95%Molecular weight:1,117.4 g/molNicaraven
CAS:Hydroxyl radical scavenger; anti-vasospasticFormula:C15H16N4O2Purity:Min. 95%Molecular weight:284.31 g/molTraxoprodil
CAS:Controlled ProductNMDA glutamate receptor antagonist; anti-depressant
Formula:C20H25NO3Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:327.42 g/molTolvaptan - Bio-X ™
CAS:Controlled ProductTolvaptan is a vasopressin receptor antagonist. It binds to the V2 receptor in the cytosol and prevents it from activating the aquaporin 2 channel, which regulates water permeability. Inhibition of vasopressin receptors in the kidneys improves fluid and electrolyte balance. Tolvaptan has been shown to be effective for treating congestive heart failure, as well as other disorders that are associated with fluid retention, such as renal dysfunction and metabolic syndrome. Tolvaptan can also be used in combination therapy with other drugs to treat these conditions.
Formula:C26H25ClN2O3Purity:Min. 95%Color and Shape:PowderMolecular weight:448.94 g/molMitomycin C - Bio-X ™
CAS:Mitomycin C is a cytotoxic agent that belongs to the class of mitomycins. It has been used for the treatment of a range of cancers and for ocular surface diseases, such as the glaucoma surgery trabeculectomy. In this case it is administered to reduce post-operative scarring which could otherwise lead to failure of the procedure. Mitomycin C is an alkylating antibiotic that inhibits DNA synthesis by cross-linking the DNA double helix. Mitomycin C also stimulates the production of transforming growth factor β1 (TGF-β1) and basic fibroblast growth factor (bFGF). Clinically, mitomycin can be used both intravenously and topically, and has been studied in a range of wound healing models.Formula:C15H18N4O5Purity:Min. 95%Color and Shape:PowderMolecular weight:334.33 g/mol7-Prenyloxycoumarin
CAS:7-Prenyloxycoumarin is a naturally occurring compound, often categorized as a phytochemical, which is primarily isolated from various plant sources including the Rutaceae family. This compound exhibits intriguing biochemical properties due to its unique molecular structure, primarily the presence of a prenyloxy group attached to the coumarin core. The mode of action of 7-Prenyloxycoumarin primarily involves its ability to interact with biological membranes and proteins, leading to modulation of enzymatic activity and disruption of pathogen cell walls.Formula:C14H14O3Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:230.26 g/molPamidronic acid disodium hydrate - Bio-X ™
CAS:Pamidronic acid is a bisphosphate used in the treatment of Paget’s disease, osteolytic bone lesions and in the treatment of hypercalcemia of malignancy. This drug inhibits farnesyl diphosphate and induces apoptosis of hematopoietic tumor cells.Formula:C3H9NNa2O7P2·4H2OPurity:Min. 95%Color and Shape:PowderMolecular weight:351.11 g/molSR 4835
CAS:SR 4835 is a synthetic compound, which is an advanced molecular entity derived from extensive medicinal chemistry efforts. This compound exhibits a novel mechanism of action, targeting specific cellular pathways implicated in disease processes. SR 4835 functions by modulating enzyme activity, thus influencing intracellular signaling cascades that play a critical role in pathophysiological conditions.
Formula:C21H20Cl2N10OPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:499.36 g/mol(5Z)-7-Oxozeaenol
CAS:(5Z)-7-Oxozeaenol is a potent and selective small-molecule inhibitor, primarily characterized as a natural product derived from fungal sources. It specifically targets and inhibits transforming growth factor-beta (TGF-β) type I receptor kinase, also known as activin receptor-like kinase 5 (ALK5), as well as TAO kinases. The inhibition occurs through covalent modification, which results in the suppression of downstream signaling pathways that are crucial in various cellular processes.Formula:C19H22O7Purity:Min. 95%Color and Shape:PowderMolecular weight:362.37 g/molBRD 6989
CAS:A small molecule inhibitor with high selectivity for CDK8 over CDK19. Increases IL-10 production in stimulated human and murine macrophages and dendritic cells. Modulatory action on inflammatory responses has therapeutic potential.Formula:C16H16N4Purity:Min. 95%Color and Shape:SolidMolecular weight:264.33 g/molDacomitinib
CAS:Pan-EGFR inhibitor (HER1, HER2 and HER4); antineoplasticFormula:C24H25ClFN5O2Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:469.95 g/molPonalrestat
CAS:Ponalrestat is an aldose reductase inhibitor, which is a synthetic compound developed for pharmacological purposes. It originates from chemical synthesis designed to target and inhibit the enzyme aldose reductase effectively. The mode of action involves the competitive inhibition of aldose reductase, an enzyme involved in the polyol pathway of glucose metabolism. By preventing the reduction of glucose to sorbitol, it reduces sorbitol accumulation associated with diabetic complications.Formula:C17H12BrFN2O3Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:391.19 g/molPitolisant hydrochloride
CAS:Pitolisant is an inverse agonist and antagonist of the histamine (H3) receptor. It acts as an allosteric modulator of the H3 receptor to increase the activity of histamine at the M1 receptor. Pitolisant has been used in the treatment of narcolepsy, schizophrenia and Alzheimer's disease. Its mechanism of action involves binding to the amide group on histamine, which increases its affinity for the H3 receptor and enhances its activity at this site. Pitolisant has been shown to improve cognitive ability and reduce fatigue in patients with Alzheimer's disease.
Formula:C17H26ClNO·HClPurity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:332.31 g/molSDZ 220-581 hydrochloride
CAS:NMDA receptor antagonistFormula:C16H17ClNO5P•HClPurity:Min. 95%Molecular weight:406.2 g/molDarolutamide
CAS:Androgen receptor antagonist; therapy for endometriosis
Formula:C19H19ClN6O2Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:398.86 g/molMethotrexate sodium
CAS:Inhibitor of folate synthesis; folic acid analogueFormula:C20H22N8O5•NaxPurity:Min. 95%Molecular weight:476.42 g/molVolitinib
CAS:Inhibitor of c-Met kinaseFormula:C17H15N9Purity:Min. 95%Color and Shape:White PowderMolecular weight:345.36 g/molL 838417
CAS:Selective partial GABAA receptor antagonist of subtypes α1, α2, α3, α5 subunits. Non-sedative anxiolytic effects demonstrated in vivo, without compromising motor activity. Anti-nociceptive and anti-inflammatory activities also demonstrated in vivo.Formula:C19H19F2N7OPurity:Min. 95%Color and Shape:White/Off-White SolidMolecular weight:399.4 g/molNilotinib HCl monohydrate - Bio-X ™
CAS:Nilotinib is a kinase inhibitor that is used for the treatment of Chronic Myeloid Leukemia (CML). This drug is also used for the treatment of CML that is resistant to imatinib. Nilotinib inhibits the tyrosine kinase activity of the BCR-ABL protein. It also inhibits PDGFR and c-kit.
Formula:C28H22F3N7O•HCl•H2OPurity:Min. 95%Color and Shape:PowderMolecular weight:583.99 g/molSemaglutide
CAS:Anti-diabetic and anti-obesity drug. We also have the heavy labelled material, CRB1301886. Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.Formula:C187H291N45O59Purity:Min. 99.0 Area-%Color and Shape:PowderMolecular weight:4,113.58 g/molXL184
CAS:Pan-tyrosine kinase inhibitor (VEGFR2, c-MET, RET, KIT); anti-neoplasticFormula:C28H24FN3O5Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:501.51 g/molSCH 23390 hydrochloride
CAS:Antagonist of D1-like dopamine receptor subtypes, D1 and D5 (Ki values 0.2 and 0.3 nM respectively). Agonist of serotonin receptors 5-HT1C and 5-HT2C (Ki values 6.3 nM and 9.3 nM respectively). Used to study the topography of D1 receptors in humans and animals. Reduces seizures in response to chemoconvulsants and has also been studied in other neurological disorders.Formula:C17H18ClNO·HClPurity:Min. 95%Color and Shape:White/Off-White SolidMolecular weight:324.24Levetiracetam - Bio-X ™
CAS:Controlled ProductLevetiracetam is a modulates the activity of the synaptic vesicle protein 2A (SV2A) in the brain and is used to treat epilepsy.It is not clear exactly how Levetiracetam affects the activity of SV2A and if this is through inhibiting the release of neurotransmitters. However, it is thought to work by binding to a specific site on SV2A, which interferes with its normal function and ultimately leads to changes in exocytosis. One of the postulated mechanisms of action is that this modulates glutamate release. Levetiracetam is used to treat certain types of seizures in people with epilepsy.
Levetiracetam is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formula:C8H14N2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:170.21 g/mol(±)-Vasicine
CAS:(±)-Vasicine is an alkaloid compound, which is a naturally occurring, organic molecule found primarily in the plant Adhatoda vasica. This alkaloid is extracted from the leaves of the plant, which is native to parts of Asia, particularly India and Pakistan. (±)-Vasicine is known for its bronchodilatory and respiratory stimulant activities.
Formula:C11H12N2OPurity:Min. 90%Color and Shape:PowderMolecular weight:188.23 g/molCariprazine
CAS:Partial agonist of D2 and D3 dopamine receptors; anti-psychoticFormula:C21H32Cl2N4OPurity:Min. 95%Color and Shape:White PowderMolecular weight:427.41 g/molBrimonidine
CAS:Alpha-2-adrenoceptor agonist; reduces intraocular pressureFormula:C11H10BrN5Purity:Min. 95%Color and Shape:PowderMolecular weight:292.13 g/molCandesartan - Bio-X ™
CAS:Candesartan is a drug that belongs to the class of angiotensin II receptor antagonists and is used to treat hypertension. It is used in combination therapy with other drugs, such as hydrochlorothiazide and amlodipine, to lower blood pressure. Candesartan inhibits the formation of angiotensin II, the receptor which causes vasoconstriction and increased blood pressure.
Formula:C24H20N6O3Purity:Min. 95%Color and Shape:PowderMolecular weight:440.45 g/molNL 1
CAS:Inhibits the mitochondrial outer mebrane protein mitoNEET, anti-leukaemicFormula:C18H25NO3SPurity:Min. 95%Color and Shape:SolidMolecular weight:335.46 g/molLestaurtinib
CAS:Lestaurtinib is a multitarget tyrosine kinase inhibitor of the JAK, FLT-3 and TrkA families of tyrosine kinases at nanomolar concentrations. It inhibits proliferation and induces apoptosis in vitro. Lestaurtinib is a FDA approved orphan drug for acute myeloid leukemia.Formula:C26H21N3O4Purity:Min. 95%Color and Shape:PowderMolecular weight:439.46 g/molRS 127445 hydrochloride
CAS:A selective antagonist of serotonin 5-HT2B receptors, inhibiting inositol phosphate formation and calcium release. Blocks 5-HT-induced contraction in rat stomach fundus. Reduces fecal output in vivo, upon inhibition of 5-HT2B by RS 127445, demonstrating a potential role for this receptor in colonic motility. Inhibits visceral hypersensitivity induced by restraint stress or colonic inflammation.Formula:C17H16FN3·HClPurity:Min. 95%Color and Shape:White To Yellow SolidMolecular weight:317.79 g/molPitolisant hydrochloride - Bio-X ™
CAS:Pitolisant is an inverse agonist and antagonist of the histamine (H3) receptor. It acts as an allosteric modulator of the H3 receptor to increase the activity of histamine at the M1 receptor. Pitolisant has been used in the treatment of narcolepsy, schizophrenia and Alzheimer's disease. Its mechanism of action involves binding to the amide group on histamine, which increases its affinity for the H3 receptor and enhances its activity at this site. Pitolisant has been shown to improve cognitive ability and reduce fatigue in patients with Alzheimer's disease. Pitolisant is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formula:C17H26ClNO·HClPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:332.31 g/molEltrombopag - Bio-X ™
CAS:Eltrombopag is an agonist of thrombopoietin receptor TpoR, which triggers activation of the JAK2/STAT5 signalling pathway. This drug is indicated in individuals with thrombocytopenia since it leads to increased proliferation of megakaryocyte progenitor cells and increased production of platelets. Eltrombopag also enhances expansion of human umbilical cord blood hematopoietic stem/primitive progenitor cells and promotes hematopoiesis.Formula:C25H22N4O4Purity:Min. 95%Color and Shape:PowderMolecular weight:442.47 g/molCP 671305
CAS:Inhibitor of PDE4 enzyme
Formula:C23H19FN2O7Purity:Min. 95%Color and Shape:SolidMolecular weight:454.4 g/molPipethanate ethobromide
CAS:Prostaglandin E2 (EP2) receptor antagonistFormula:C23H30NO3•BrPurity:Min. 95%Color and Shape:White PowderMolecular weight:448.39 g/molNeu5Ac[1Me,4789Ac]a(2-3)Gal[246Bz]-b-MP
CAS:Neu5Ac[1Me,4789Ac]a(2-3)Gal[246Bz]-b-MP is a synthetic glycan, which is a complex carbohydrate molecule modeled after naturally occurring glycoconjugates. This product is derived through chemical synthesis in the laboratory, allowing precise control over its structure and functional groups. It consists of sialic acid (Neu5Ac) linked to galactose (Gal), with several protective acetyl (Ac) and benzyl (Bz) groups that confer stability during synthesis and ensure high specificity in its interactions.
Formula:C54H57NO22Purity:Min. 95 Area-%Color and Shape:PowderMolecular weight:1,072.02 g/molValdecoxib
CAS:Controlled ProductCOX-2 inhibitor; anti-inflammatoryFormula:C16H14N2O3SPurity:Min. 95%Color and Shape:White PowderMolecular weight:314.36 g/molTenatoprazole
CAS:H+/K+ ATPase inhibitorFormula:C16H18N4O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:346.41 g/molAR-R 17779 hydrochloride
CAS:AR-R 17779 is a selective agonist for α7 nicotinic acetylcholine receptors (nAChRs) (Ki value = 190 nM for rat α7 receptor). This compound has use as a tool to study the function of α7 nicotinic receptors. One such study revealed a role for α7 nicotinic receptors in nicotine-mediated excitatory effects on hippocampal learning and memory. AR-R17779 reduces formation of atherosclerotic plaques and abdominal aortic aneurysms in apolipoprotein E-deficient mice.Formula:C9H14N2O2•HClPurity:Min. 95%Color and Shape:White PowderMolecular weight:218.68 g/molKV 37
CAS:Inhibitor of AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase)Formula:C23H25NO3Purity:Min. 95%Color and Shape:PowderMolecular weight:363.45 g/molPNU 159682
CAS:DNA alkylating agent; highly potent metabolite of nemorubicinFormula:C32H35NO13Purity:Min. 90 Area-%Color and Shape:Red PowderMolecular weight:641.62 g/molGNE 371
CAS:A chemical probe for the dual bromodomains of human transcription-initiation-factor TFIID subunit 1 (TAF1). GNE 371 binds TAF1 with an IC50 of 10 nM and is selective over other bromodomain family members. Exerts anti-proliferative effects in synergy with BET inhibitor JQ1.
Formula:C24H25N5O3Purity:(Hplc-Ms) Min. 98 Area-%Molecular weight:431.49 g/molPentoxifylline
CAS:Controlled ProductPhosphodiesterase inhibitorFormula:C13H18N4O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:278.31 g/molPYR 41
CAS:PYR-41 is a small molecule inhibitor, which is sourced from chemical synthesis. It functions primarily by targeting ubiquitin-activating enzymes, particularly the E1 enzyme, to disrupt the ubiquitination process. This mechanism effectively hampers the transfer of ubiquitin to substrate proteins, thereby modulating protein degradation and signaling pathways.Formula:C17H13N3O7Purity:Min. 95%Molecular weight:371.3 g/molAZD 5069
CAS:CXCR2 antagonist
Formula:C18H23F2N5O4S2Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:475.11595GSK 1120212B
CAS:Inhibits MEK1 and MEK2 kinases; targeted therapy for melanomaFormula:C26H23FIN5O4•C2H6OSPurity:Min. 95%Color and Shape:PowderMolecular weight:693.53 g/mol
